Jildaz Caroff 👨🏻‍⚕️

Among patients with stroke due to medium-vessel occlusion, thrombectomy led to functional independence at 90 days (in 58.6% of patients, vs. 46.6% with medical management) but also to a higher risk of intracranial hemorrhage. Full ORIENTAL-MeVO trial results: nej.md/42z7dNj Editorial: Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population nej.md/4d9ALY4

📣 JNIS Journal Club TOMORROW | Thursday, May 7, 4 PM ET Authors @jildazz and Dr. Diego Alejandro Hernandez Langarica join JNIS Social Media Associate Editor @DanniDiestro and discussants @drricardohanel and Dr. Laetitia de Villiers to discuss thrombus migration after tenecteplase and intravascular lithotripsy for calcified carotid stenosis. 🔗 Register: bit.ly/4d5vG1x

The next @JNIS_BMJ Journal Club is Thursday, May 7 at 4pm ET. Authors @jildazz & Diego Alejandro Hernandez Langarica, MD will sit down with JNIS Social Media Associate Editor @DanniDiestro & discussants Ricardo Hanel, MD, PhD & Laetitia de Villiers, MBBS, FRANZCR.

🧠 Have you treated a wide-neck #aneurysm, a dissection, or an intracranial stenosis using the pEGASUS HPC Stent System? Send your best case to our contest jury 👉 linnc.com/News/2026/Clin… 🏆 The winner will: • Receive a pass to #LINNCParis 2026, including registration and travel support • Present his case during the Course Take this chance to gain immediate recognition!

🧠💉 In TNK-treated LVO stroke patients eligible for EVT, thrombus migration occurred in 36% and made EVT impossible in 26% vs 4% without migration. Thrombus migration significantly reduced rates of complete reperfusion but did not affect functional outcomes. Read more here: bit.ly/4lpk658 @jildazz

It was truly an honor to support @Medtronic in the launch of #Vantage FD in China 🇨🇳 I’m very grateful for the warm welcome from our Chinese colleagues and for the quality of the exchanges throughout this journey #HappyNewYear 🐴🪽

Investigating child sexual abuse material isn’t controversial. Turning it into political theater is manipulation. Maybe that logic flies on some island. Doesn’t fly in France.

ABC WIN 2026 through the eyes of Jildaz Caroff! 👉 linnc.com/News/2026/ABC-… From venous disorders and CSF leaks to AI, robotics, and procedural safety, neurointervention is evolving beyond isolated technical success toward system-level care optimization. For LINNC online, @jildazz shares his personal take on the trends, innovations, and challenges shaping the discipline—from venous pathology and imaging-driven patient selection to procedural safety. 📖 Read the full report and join the discussion: what are your key takeaways from ABC WIN 2026? #ABCWIN #ABCWIN2026 #neurointervention

@CWong94262 Good to know 😉

@jildazz Arachnoid granulations (AG) is the most common cause of IIH, and AG is soft. No post dilate needed with over 20 cases I have seen. For your case, the stenosis was likely due to the size irregularity of the transverse sigmoid segment and Casper is poor in design to make it nice.

@CWong94262 Interesting. Any hemorrhage risk associated with post dilatation?

@jildazz Acclino 8mm is closed cell with very little metal coverage, so even post dilatation is required, the passage of the balloon is very un-likely to cause damage on the stent. With Casper, the passage of the balloon could potential make the damage if the stent is stenotic.

@CWong94262 Thanks for your input and recommendations The stent was finally not implanted In your experience Acclino stent has more radial force than the CASPER stent, interesting, I will consider it next time. What if it does not expand neither ??

@jildazz Pull the stent out, that stent looks poorly designed (material, braiding…). It will damage the patient rather than help no matter how hard you have tried intra-op. It will become embolization device very soon.

Is #intrasaccular the new gold standard for bifurcation #aneurysm treatment? ➡️ brnw.ch/21wWE6q @Jildazz reveals key clinical benefits and insights. 🎥 Watch the video and discover why this approach is reshaping aneurysm care!

💡 The webinar is over, but the insights live on! 🎥 Watch the full replay now: tinyurl.com/9kbbsehp Join Laurent Spelle, @jildazz , @CDargazanli , and Monika Killer as they share their knowledge and real-world experience on how next-generation #intrasaccular devices optimise #aneurysm treatment & improve patient outcomes. Key insights include: 🔹 Benefits and indications for intrasaccular devices vs stent-assisted coiling for wide-neck bifurcation aneurysms 🔹 Key takeaways from the #Artisse INSPIRE 12-month follow-up data 🔹 Practical tips for case selection & device sizing 🔹 Real-world experience from 100+ cases 🔹 Expert perspectives on enhancing patient outcomes

⏰ Only 1 hour to go! Join our free LIVE webinar: “How do next-generation #intrasaccular devices optimise #aneurysm treatment & improve patient outcomes?” 📅 Today, 29 Sep 2025 – 5 PM 👨‍⚕️👩🏻‍⚕️ Laurent Spelle, @jildazz , Monika Killer & @CDargazanli Secure your spot now: tinyurl.com/y37hr2x7 Don’t miss insights from leading experts on the benefits of intrasaccular devices versus stent-assisted coiling for wide-neck bifurcation aneurysms, clinical case discussions, and a review of 12-month follow-up data from the Artisse INSPIRE study!

🚨 Only a few days to go! Secure your spot for our free webinar on next-generation #intrasaccular devices for aneurysm treatment: ow.ly/BcAq50X0MBI 📅 Monday, 29 September 2025 – 5 PM 👨‍⚕️ Laurent Spelle, @jildazz , @CDargazanli & Monika Killer What you’ll learn: ✅ Clinical indications & long-term data ✅ Insights from the 12-month Artisse INSPIRE study ✅ Practical strategies to optimise outcomes ✅ IS devices vs stent-assisted coiling for wide-neck bifurcation #aneurysms Don’t miss out!

@NN_publishing @esmintsociety Thanks for keeping us updated!

We are onsite again today at #ESMINT2025! Stop by our booth in the exhibitor hall to say hello and grab a free copy of NeuroNews @NN_publishing @esmintsociety

Our latest publication is Free open access ✅ ⬇️⬇️⬇️ Dual antiplatelet therapy practices following Pipeline Shield emboliza... sciencedirect.com/science/articl…

RIP🕊️

Joe Caroff has passed away at age 103 He designed the iconic James Bond 007 logo

Only 0.1% (1/707) Major Stroke or Death after DAPT discontinuation in a Pipeline Flex Shield cohort. bit.ly/3UqYSqJ No interaction with time❗️How can we improve our standards from there? @jildazz @DoctorGaldamez @Medtronic_NV @eppdata_ @GuenegoAdrien